Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumors
Abstract Background A limitation of approved oncolytic viruses is their requirement for intratumoral (i.t.) injection. TILT-123 (igrelimogene litadenorepvec, Ad5/3-E2F-D24-hTNFα-IRES-hIL-2) is a chimeric oncolytic adenovirus suitable for intravenous (i.v.) delivery due to its capsid modification and...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2024-11-01
|
| Serier: | Journal of Experimental & Clinical Cancer Research |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s13046-024-03219-0 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
